NeuroMetrix Showcases Quell Wearable Pain Relief Device At International Consumer Electronics Show 2015

NeuroMetrix Showcases Quell Wearable Pain Relief Device At International Consumer Electronics Show 2015
Waltham, Massachusetts based NeuroMetrix, Inc. unveiled and demonstrated its novel "Quell" wearable pain relief device at the 2015 International Consumer Electronics show (CES) this week in Las Vegas. NeuroMetrix was also chosen for inclusion in an exclusive group participating in CES Unveiled, the official CES press event, and the company's Shai N. Gozani, M.D., Ph.D., was interviewed in the Digital Health LIVE CES WebMD Lounge. A video of the interview can be viewed here. The technology used in Quell utilizes NeuroMetrix's proprietary non-invasive neurostimulation technique aimed at providing relief from chronic pain, such as due to diabetes, sciatica, fibromyalgia, and degenerative knee function. The lightweight, advanced, wearable pain relief device is designed to be on call 24 hours a day, worn during daytime activities as well as in bed at night. It is claimed to automatically track sleep quality and automatically adjust to ensure the relief you need to sleep soundly. Quell has been cleared by the FDA for chronic pain management and treatment without a prescription, and users will also have the option of using their smartphone to automatically track and personalize their Quell-based pain therapy. The company claims that users will experience relief in as little as 15 minutes, and that Quell technology works with the wearer's own body by both stimulating nerves and by blocking pain signals to the brain. Consumers and medical professionals can learn more and sign up to receive information at: http://QuellRelief.com. NeuroMetrix expects to begin taking pre-orders for Quell in March for shipment beginning during the second quarter of 2015. The Quell device will initially be available exclusively through doctors' offices and online. Que
Subscribe or to access all post and page content.